Seagen Inc. (United States) is listed on the Nasdaq and has a market capitalization of $43.03 Billions, with shareholders equity totaling $2.55 Billions.
The company employs approximately 2.092 people and operates in the Health Care sector, within the Biotechnology industry.
Over the past 12 months, Seagen Inc. reported $2.30 Billions in revenue, generating net income of $-750.23 Millions.
Key financial metrics include a P/E ratio of -57.36, a price-to-book (P/B) ratio of 16.87, and a trailing twelve-month dividend yield of 0.00%.
The company trades under the ticker SGEN.